step 1 what are the steps of the procedure? step 3 ...€¦ · v i d e o s e r i e s s u m m a r y...

VIDEO SERIES SUMMARY GUIDE FDA Approval: 2018 Company Name: Glaukos Material/Dimensions: Titanium Indications: W/cataract surgery, for early to moderate open angle glaucoma What are the steps of the procedure? Good Patient Selection Research Graph/ Chart Step 1 Enter corneal wound w/inserter & put on gonioprism Step 2 Step 3 Retract Tip & Place trocar in TM perpendicular Dimple, press release, then repeat 2-3 clk hours away. Step 4 Examine stents placement. Why would I choose this device? Mechanism of Acion The stents penetrate the trabecular meshwork, creating a stable bypass route for aqueous and allowing increased access to Schlemm's canal and outflow channels for up to 6 clk hours. This lowers IOP. -combined with cataract surgery - primary open angle - early to moderate stage on 1 or more medications Patients to Avoid -heavy angle synechia - NVA/ NVG - Plateua Iris - Traumatic Glaucoma Recussion Picture of device alone Safety equivalent to cataract surgery alone. Potential complications low. Minimal bleeding, no hypotony or corneal edema. Efficacy - 31 % avg reduction from baseline, or 7.0 mmHg avg reduction in IOP seen in FDA clinical trials. In Germany study, 37% avg reduction for 3 years. What Where Why How Who iGlaucoma You Tube Channel - Glaucoma Innovation Made Easy For Eye Care Professionals iGlaucoma You Tube Channel Glaucoma Innovation Made Easy For Eye Care Professionals iStent Inject

Upload: others

Post on 18-Oct-2020

4 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

VIDEO SERIESSUMMARY GUIDE

FDA Approval: 2018Company Name: GlaukosMaterial/Dimensions: Titanium Indications: W/cataract surgery, for early to moderateopen angle glaucoma

What are the steps of the procedure?

Good Patient Selection

ResearchGraph/Chart

Step 1Enter corneal

woundw/inserter & puton gonioprism

Step 2

Step 3

Retract Tip & Place trocar

in TM perpendicular

Dimple, pressrelease, thenrepeat 2-3 clkhours away.

Step 4

Examine stents

placement.

Why would I choose this device?

Mechanism of AcionThe stents penetrate the trabecular

meshwork, creating a stable bypass route foraqueous and allowing increased access to

Schlemm's canal and outflow channels for upto 6 clk hours. This lowers IOP.

-combined with cataract surgery- primary open angle- early to moderate stage on 1 ormore medications

Patients to Avoid -heavy angle synechia

- NVA/ NVG- Plateua Iris- Traumatic GlaucomaRecussion

Picture ofdevicealone

Safety equivalent to cataractsurgery alone. Potential complications low.Minimal bleeding, no hypotonyor corneal edema.

Efficacy - 31 % avg reductionfrom baseline, or 7.0 mmHgavg reduction in IOP seen inFDA clinical trials.In Germany study, 37% avgreduction for 3 years.

What

Where

Why

How

Who

iGlaucoma You Tube Channel - Glaucoma Innovation MadeEasy For Eye Care Professionals

iGlaucoma You Tube ChannelGlaucoma Innovation Made Easy For Eye Care Professionals

iStent Inject

D. Western Therapeutics Institute Inc. Impact of Glaukos

NOTICE OF ANNUAL MEETING OF STOCKHOLDERSs21.q4cdn.com/471661912/files/doc_financials/2019/Glaukos-2019-… · Technologies Corporation, a global life sciences company, prior to its

Glaukos Corporation

W O R K S H E E T S · Web viewW O R K S H E E T S W O R K S H E E T S W O R K S H E E T S W O R K S H E E T S W O R K S H E E T S C O N T E N T S WORKSHEET 1 : Subject Pronouns and